Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 10
1992 15
1993 26
1994 24
1995 50
1996 74
1997 64
1998 105
1999 145
2000 159
2001 163
2002 177
2003 181
2004 216
2005 249
2006 227
2007 267
2008 275
2009 245
2010 287
2011 309
2012 255
2013 281
2014 261
2015 213
2016 162
2017 151
2018 131
2019 144
2020 97
2021 116
2022 91
2023 70
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

4,944 results

Results by year

Filters applied: . Clear all
Page 1
Nevirapine hypersensitivity.
Popovic M, Shenton JM, Chen J, Baban A, Tharmanathan T, Mannargudi B, Abdulla D, Uetrecht JP. Popovic M, et al. Handb Exp Pharmacol. 2010;(196):437-51. doi: 10.1007/978-3-642-00663-0_15. Handb Exp Pharmacol. 2010. PMID: 20020271 Review.
Treatment of HIV-1 infections with nevirapine is associated with skin and liver toxicity. These two organ toxicities range from mild to severe, in rare cases resulting in life-threatening liver failure or toxic epidermal necrolysis. The study of the mechanistic steps leadi …
Treatment of HIV-1 infections with nevirapine is associated with skin and liver toxicity. These two organ toxicities range from mild …
NNRTIs: future prospects.
Dellamonica P, Di Perri G, Garraffo R. Dellamonica P, et al. Med Mal Infect. 2012 Jul;42(7):296-300. doi: 10.1016/j.medmal.2012.05.005. Epub 2012 Jun 23. Med Mal Infect. 2012. PMID: 22727648 Review.
Recent clinical data on efavirenz and nevirapine in naive patients confirms their effectiveness compared to protease inhibitors such as lopinavir/r (ACTG 5142) or atazanavir/r (ACTG 5202) for efavirenz, or such as atazanavir/r (ARTEN trial) for nevirapine. ...Their …
Recent clinical data on efavirenz and nevirapine in naive patients confirms their effectiveness compared to protease inhibitors such …
Is it safe to switch between efavirenz and nevirapine in the event of toxicity?
Mehta U, Maartens G. Mehta U, et al. Lancet Infect Dis. 2007 Nov;7(11):733-8. doi: 10.1016/S1473-3099(07)70262-1. Lancet Infect Dis. 2007. PMID: 17961859 Review.
Hepatitis did not recur in either the 11 reported patients switched from nevirapine to efavirenz, or in the single reported patient who was switched from efavirenz to nevirapine. Substituting efavirenz for nevirapine following hepatotoxicity or cutaneous hype …
Hepatitis did not recur in either the 11 reported patients switched from nevirapine to efavirenz, or in the single reported patient w …
Nevirapine-induced agranulocytosis.
Pérez Pedrero D, Górgolas M, Fernández Guerrero ML. Pérez Pedrero D, et al. J Chemother. 2011 Apr;23(2):117. doi: 10.1179/joc.2011.23.2.117. J Chemother. 2011. PMID: 21571631 No abstract available.
Nevirapine in the treatment of HIV.
Milinkovic A, Martínez E. Milinkovic A, et al. Expert Rev Anti Infect Ther. 2004 Jun;2(3):367-73. doi: 10.1586/14787210.2.3.367. Expert Rev Anti Infect Ther. 2004. PMID: 15482202 Review.
As with any antiretroviral drug, nevirapine should always be used as part of a fully suppressive regimen. ...Nevirapine also has an important role in preventing mother-to-child transmission of HIV. ...
As with any antiretroviral drug, nevirapine should always be used as part of a fully suppressive regimen. ...Nevirapine also h …
The role of nevirapine in the treatment of HIV-1 disease.
Podzamczer D, Fumero E. Podzamczer D, et al. Expert Opin Pharmacother. 2001 Dec;2(12):2065-78. doi: 10.1517/14656566.2.12.2065. Expert Opin Pharmacother. 2001. PMID: 11825335 Review.
Nevirapine is well-tolerated, rash being the most common severe adverse effect observed. Hepatotoxicity may also appear with nevirapine, mainly in patients with chronic hepatitis C and/or altered liver function tests. ...
Nevirapine is well-tolerated, rash being the most common severe adverse effect observed. Hepatotoxicity may also appear with nevir …
Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity.
Marinho AT, Miranda JP, Caixas U, Charneira C, Gonçalves-Dias C, Marques MM, Monteiro EC, Antunes AMM, Pereira SA. Marinho AT, et al. Drug Metab Rev. 2019 Feb;51(1):76-90. doi: 10.1080/03602532.2019.1577891. Epub 2019 Mar 29. Drug Metab Rev. 2019. PMID: 30712401 Review.
Nevirapine (NVP) is a first-generation non-nucleoside reverse transcriptase inhibitor widely used for the treatment and prophylaxis of human immunodeficiency virus infection. ...
Nevirapine (NVP) is a first-generation non-nucleoside reverse transcriptase inhibitor widely used for the treatment and prophylaxis o …
Nevirapine: pharmacokinetic considerations in children and pregnant women.
Mirochnick M, Clarke DF, Dorenbaum A. Mirochnick M, et al. Clin Pharmacokinet. 2000 Oct;39(4):281-93. doi: 10.2165/00003088-200039040-00004. Clin Pharmacokinet. 2000. PMID: 11069214 Review.
Nevirapine is a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase. ...Nevirapine elimination is prolonged in pregnant women during labour and in newborns. ...
Nevirapine is a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase. ...Nevirapine elimination is prolonged in preg …
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Chintu C, Gibb DM, Walker AS, Burger DM; CHAPAS-1 trial team. Fillekes Q, et al. AIDS. 2013 Aug 24;27(13):2111-5. doi: 10.1097/QAD.0b013e3283620811. AIDS. 2013. PMID: 23595153 Clinical Trial.
OBJECTIVES: Young children metabolize nevirapine faster than older children/adults. We evaluated nevirapine pharmacokinetics with or without dose-escalation in Zambian, HIV-infected infants/children and its relationship with safety/efficacy. ...METHODS: HIV-infected …
OBJECTIVES: Young children metabolize nevirapine faster than older children/adults. We evaluated nevirapine pharmacokinetics w …
Nevirapine modulation of paraoxonase-1 in the liver: An in vitro three-model approach.
Marinho AT, Dias CG, Pinheiro PF, Lemos AR, Antunes AM, Marques MM, Monteiro EC, Miranda JP, Pereira SA. Marinho AT, et al. Eur J Pharm Sci. 2016 Jan 20;82:147-53. doi: 10.1016/j.ejps.2015.11.019. Epub 2015 Nov 25. Eur J Pharm Sci. 2016. PMID: 26620700
Both nevirapine and 12-hydroxy-nevirapine increased POase (p<0.05, p<0.01) and LACase activities (p<0.05, p<0.001). The AREase activity was increased only upon 12-hydroxy-nevirapine exposure (p<0.01). These modulatory effects were observed at 3 …
Both nevirapine and 12-hydroxy-nevirapine increased POase (p<0.05, p<0.01) and LACase activities (p<0.05, p<0.001) …
4,944 results